Jason Aryeh - Dec 22, 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LGND	Non-Qualified Stock Option (right to buy)	Award	$0	+4.48K		$0.00	4.48K	Dec 22, 2022	Common Stock	4.48K	$67.03	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Grant to reporting person of stock options that will vest and become exercisable on December 22, 2023.

Exhibit 24 - Power of Attorney.